Beta Drugs reports Q2FY26 financial results.

Beta Drugs reports Q2FY26 financial results. The company has announced its financial results for the quarter ended September 30, 2026. Results were in line with market expectations, with no major deviations in revenue or profit. No guidance update or significant corporate actions were disclosed.

📊 STOCKS: BETADRUG | 🏢 SECTOR: Pharma | #LOWIMPACT #Earnings